Acute cardiac care & resuscitation

Early-Phase Trajectory of Right Ventricular Hemodynamics during Microaxial Flow Pump Support for Cardiogenic Shock

JACC AdvPublished registry study

Authors' conclusion

In patients with cardiogenic shock supported by PVAD, the early trajectory of hRVD provides prognostic information. Persistent or worsening hRVD at 24 hours identifies high-risk patients and may guide timely escalation of right-heart-targeted therapies. (UNLOADERS-PVAD [Unloading and Heart Recovery with Advanced Mechanical Circulatory Support: Optimal Management of Percutaneous Ventricular Assist Device] UMIN000052966).

Study context

Population
Patients with cardiogenic shock treated with percutaneous ventricular assist device (PVAD) from the UNLOADERS-PVAD registrypatients with available data
Participants
463 patients
Exposure
Persistent or worsening hemodynamic RVD (hRVD) at 24 h post-PVAD vs other hRVD trajectories
Outcome
Composite of:
  • All-cause mortality
  • Reintroduction of mechanical circulatory support after PVAD discontinuation
Follow-up
Within 30 days

Main finding

As reported in the abstract

  • Persistent or worsening hRVD at 24 h post-PVAD was associated with a higher risk of the primary endpoint

Observational data: associations, not effects.

Further findings

Prevalence of hRVD

pre-PVAD
52% (63/121)
Early post-PVAD
48% (211/443)
24 h post-PVAD
39% (169/436)

hRVD trajectories

Heterogeneous, with improvement predominating over deterioration

Follow-up

Median follow-up from PVAD implantation
27 (12-30) days

Components of hRVD and adverse outcomes

Elevated right atrial pressure associated with adverse outcomes only at 24 h post-PVAD
Low pulmonary artery pulsatility index consistently associated with adverse outcomes across all time points

Original publication

Early-Phase Trajectory of Right Ventricular Hemodynamics during Microaxial Flow Pump Support for Cardiogenic Shock. JACC Adv. Published 19 August 2026. doi:10.1016/j.jacadv.2026.103165

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.